预后免疫营养指数与腹腔镜结肠癌患者预后的相关性分析
Analysis on Correlation between Prognostic Immunenutritional Index with Prognosis of Patients with Colon Cancer after Laparoscopic Surgery
DOI: 10.12677/ACM.2023.1381781, PDF,  被引量   
作者: 刘 伟, 于 洋, 陈占峰, 庄加红, 房绍馨, 许崇祥*:日照市人民医院普外科,山东 日照;王 艳:日照市人民医院重症医学科,山东 日照
关键词: 预后免疫营养指数腹腔镜结肠癌预后Prognostic Immune Nutritional Index Laparoscopic Surgery Colon Cancer Prognosis
摘要: 目的:探究预后免疫营养指数(PINI)与腹腔镜下结肠癌切除患者临床病理特征的关系,及其对结肠癌患者预后的影响。方法:回顾性分析接受腹腔镜根治性切除术的210例结肠癌患者资料,采用Clavien-Dindo评分对术后并发症分级。计算患者术前PINI值,将患者分为低PINI组与高PINI组,采用χ2检验或Fisher确切概率法分析PINI与临床病理特征的关系;采用Kaplan-Meier曲线进行生存分析;应用单因素及多因素分析PINI对患者术后并发症(CD评分 ≥ 2级)及远期死亡率的影响。结果:两组患者在年龄、体重指数、CEA、T分期、淋巴结转移、肿瘤大小、住院时间、术后并发症(CD评分 ≥ 2级)均有显著差异(P < 0.05),logistic多因素回归分析得出,低PINI值(OR = 2.926, 95%CI: 1.919~3.521, P < 0.01)是影响患者术后并发症的独立危险因素;低PINI患者的5年总生存率明显低于高PNI患者(71.9% vs 84.3%, P < 0.05);采用Cox多因素生存分析提示,低PINI值(RR = 2.093, 95%CI: 2.560~8.171, P < 0.05)、T ≥ 3期(RR = 2.491, 95%CI: 1.181~5.255, P < 0.05)是患者5年生存率的独立预测因子。结论:对于腹腔镜根治性切除术的结肠癌患者,术前低PINI提示患者预后不良,PINI是影响患者预后的重要独立危险因素,有助于个性化治疗决策制定。
Abstract: Objective: To investigate the correlation between prognostic immunenutritional index and postop-erative outcomes in patients with colon cancer treated with laparoscopic surgery, and to evaluate its predictive value. Methods: The clinical data of 210 patients with colon cancer who underwent curative laparoscopic colectomy were analyzed retrospectively. Clavien-Dindo grading standard was used to evaluate postoperative complications. The patients were classifified into Low-PINI group and High-PINI group. The relationship between PINI and clinicopathological features was analyzed by χ2 test or Fisher’s exacttest; survival analysis was described by Kaplan-Meier curve; univariate and multivariate analysis were used to analyze the factors that might affect the complications (CD grade ≥ 2) and overall survival. Results: There were significant differences between the two groups in terms of age, body mass index, CEA, Clinical T status, lymph node metastasis, tumor size, hospital stay, postoperative complications (CD grade ≥ 2) (P < 0.05). The logistic regression analysis showed that Low-PINI value (OR = 2.926, 95%CI: 1.919~3.521, P < 0.01) was independent risk factors for postoperative complications. The 5-year overall survival rate of Low-PINI patients was significantly lower than those of High-PINI patients (71.9% vs 84.3%, P < 0.05). The Cox regression analysis showed that low PINI (RR = 2.093, 95%CI: 2.560~8.171, P < 0.05) and Clinical T status (T ≥ 3) (RR = 2.491, 95%CI: 1.181~5.255, P < 0.05) were independent risk factors for overall survival rate. Con-clusion: For patients with colon cancer treated with laparoscopic surgery, preoperative low PINI in-dicates poor prognosis, and PINI is an important independent risk factor affecting patient prognosis, which helps to make personalized treatment decisions.
文章引用:刘伟, 王艳, 于洋, 陈占峰, 庄加红, 房绍馨, 许崇祥. 预后免疫营养指数与腹腔镜结肠癌患者预后的相关性分析[J]. 临床医学进展, 2023, 13(8): 12703-12711. https://doi.org/10.12677/ACM.2023.1381781

参考文献

[1] 中国结直肠癌诊疗规范(2020年版) [J]. 中国实用外科杂志, 2020, 40(6): 601-625.
[2] 徐梦圆, 单天昊, 曾红梅. 2020年全球结肠癌和直肠癌发病死亡分析[J]. 江苏预防医学, 2023, 34(1): 12-16.
[3] He, L.H., Yang, B., Su, X.Q., et al. (2022) Comparison of Clinical Efficacy and Postoperative Inflammatory Response between Laparoscopic and Open Radical Resection of Colorectal Cancer. World Journal of Clinical Cases, 10, 4042-4049. [Google Scholar] [CrossRef] [PubMed]
[4] Liu, B., Yao, C. and Li, H. (2022) Laparoscopic Radical Resection of Colorectal Cancer in the Treatment of Elderly Colorectal Cancer and Its Effect on Gastrointestinal Function. Frontiers in Surgery, 9, Article 840461. [Google Scholar] [CrossRef] [PubMed]
[5] Manceau, G., Brouquet, A., Chaibi, P., et al. (2019) Multicenter Phase III Randomized Trial Comparing Laparoscopy and Laparotomy for Colon Cancer Surgery in Patients Older than 75 Years: The CELL Study, a Fédération de Recherche en Chirurgie (FRENCH) Trial. BMC Cancer, 19, Article No. 1185. [Google Scholar] [CrossRef] [PubMed]
[6] Diakos, C.I., Charles, K.A., McMillan, D.C., et al. (2014) Cancer-Related Inflammation and Treatment Effectiveness. The Lancet Oncology, 15, e493-e503. [Google Scholar] [CrossRef
[7] Liu, X., Yin, L., Shen, S. and Hou, Y. (2021) Inflammation and Cancer: Paradoxical Roles in Tumorigenesis and Implications in Immunotherapies. Genes & Diseases, 10, 151-164. [Google Scholar] [CrossRef] [PubMed]
[8] Tanio, A., Saito, H., Uejima, C., et al. (2019) A Prognostic Index for Colorectal Cancer Based on Preoperative Absolute Lymphocyte, Monocyte, and Neutrophil Counts. Surgery Today, 49, 245-253. [Google Scholar] [CrossRef] [PubMed]
[9] Jung, S.H., Hao, J., Shivakumar, M., et al. (2022) Development and Validation of a Novel Strong Prognostic Index for Colon Cancer through a Robust Combination of Laboratory Fea-tures for Systemic Inflammation: A Prognostic Immune Nutritional Index. British Journal of Cancer, 126, 1539-1547. [Google Scholar] [CrossRef] [PubMed]
[10] 吴军, 贾成功, 史传文. 腹腔镜与开放手术治疗结直肠癌的临床效果及预后分析[J]. 腹腔镜外科杂志, 2020, 25(11): 844-848.
[11] Xia, L.J., Li, W., Zhai, J.C., et al. (2020) Significance of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, Lymphocyte-to-Monocyte Ratio and Prognostic Nutritional Index for Predicting Clinical Outcomes in T1-2 Rectal Cancer. BMC Cancer, 20, Article No. 208. [Google Scholar] [CrossRef] [PubMed]
[12] Portale, G., Bartolotta, P., Azzolina, D., et al. (2023) Prognostic Role of Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte, and Lymphocyte-to-Monocyte Ratio in Operated Rec-tal Cancer Patients: Systematic Review and Meta-Analysis. Langenbeck’s Archives of Surgery, 408, Article No. 85. [Google Scholar] [CrossRef] [PubMed]
[13] Malietzis, G., Giacometti, M., Kennedy, R.H., et al. (2014) The Emerging Role of Neutrophil to Lymphocyte Ratio in Determining Colorectal Cancer Treatment Outcomes: A Systematic Review and Meta-Analysis. Annals of Surgical Oncology, 21, 3938-3946. [Google Scholar] [CrossRef] [PubMed]
[14] Jia, W., Yuan, L., Ni, H., et al. (2021) Prognostic Value of Plate-let-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio, and Lymphocyte-to-White Blood Cell Ratio in Colorectal Cancer Patients Who Received Neoadjuvant Chemotherapy. Technology in Cancer Research & Treatment, 20. [Google Scholar] [CrossRef] [PubMed]
[15] 徐贺, 冶占明, 李金, 等. 炎症因子与肿瘤关系及其机制研究进展[J]. 临床医学进展, 2021, 11(11): 4871-4876. [Google Scholar] [CrossRef
[16] Kozak, M.M., von Eyben, R., Pai, J.S., et al. (2017) The Prog-nostic Significance of Pretreatment Hematologic Parameters in Patients Undergoing Resection for Colorectal Cancer. American Journal of Clinical Oncology, 40, 405-412. [Google Scholar] [CrossRef
[17] Biró, A., Kolozsi, P., Nagy, A., et al. (2022) Significance of Preoperative Blood Tests in the Prognosis of Colorectal Cancer: A Prospective, Multicenter Study from Hungary. Jour-nal of Clinical Laboratory Analysis, 36, e24128. [Google Scholar] [CrossRef] [PubMed]
[18] Zhao, N., Xu, H., Zhou, D., et al. (2022) The Prognostic Role of Neutro-phil-to-Lymphocyte Ratio and C-Reactive Protein in Metastatic Colorectal Cancer Using Regorafenib: A Systematic Re-view and Meta-Analysis. Journal of Gastrointestinal Oncology, 13, 1772-1781. [Google Scholar] [CrossRef] [PubMed]
[19] Zhao, X., Zhou, Y., Liu, B., et al. (2023) Preoperative Neutro-phil-Lymphocyte Ratio (NLR)-Binding Fibrinogen-Albumin Ratio (FAR) Is Superior to Platelet-Lymphocyte Ratio (PLR)-Binding Fibrinogen-Albumin Ratio (FAR) and Lymphocyte-Monocyte (LMR)-Binding Fibrinogen-Albumin Ra-tio (FAR) as Predictors of Survival in Surgical Patients with Colorectal Adenocarcinoma. Medical Science Monitor, 29, e939442. [Google Scholar] [CrossRef
[20] Hamid, H.K.S., Emile, S.H. and Davis, G.N. (2022) Prognostic Sig-nificance of Lymphocyte-to-Monocyte and Platelet-to-Lymphocyte Ratio in Rectal Cancer: A Systematic Review, Me-ta-Analysis, and Meta-Regression. Diseases of the Colon & Rectum, 65, 178-187. [Google Scholar] [CrossRef
[21] Xu, F., Meng, C., Yang, Z., et al. (2022) Prognostic Nutri-tion Index Predicts Short-Term Surgical Complications in Patients with Rectal Cancer after Laparoscopic Surgery. Fron-tiers in Surgery, 9, Article 1000108. [Google Scholar] [CrossRef] [PubMed]
[22] McMillan, D.C., Watson, W.S., O’Gorman, P., et al. (2001) Al-bumin Concentrations Are Primarily Determined by the Body Cell Mass and the Systemic Inflammatory Response in Cancer Patients with Weight Loss. Nutrition and Cancer, 39, 210-213. [Google Scholar] [CrossRef
[23] Cengiz, O., Kocer, B., Sürmeli, S., et al. (2006) Are Pretreatment Serum Albumin and Cholesterol Levels Prognostic Tools in Patients with Colorectal Carcinoma? Medical Science Moni-tor, 12, CR240-7.
[24] Xie, H., Nong, C., Yuan, G., et al. (2020) The Value of Preoperative Controlling Nutritional Status Score in Evaluating Short-Term and Long-Term Outcomes of Patients with Colorectal Cancer Following Surgical Resection. Journal of Cancer, 11, 7045-7056. [Google Scholar] [CrossRef] [PubMed]
[25] Boonpipattanapong, T. and Chewatanakornkul, S. (2006) Preoperative Carcinoembryonic Antigen and Albumin in Predicting Survival in Patients with Colon and Rectal Carcinomas. Journal of Clinical Gastroenterology, 40, 592-595. [Google Scholar] [CrossRef] [PubMed]
[26] Langheinrich, M., Siebenhüner, A.R., Baecker, J., et al. (2022) NCR, an Inflammation and Nutrition Related Blood-Based Marker in Colon Cancer Patients: A New Promising Biomarker to Predict Outcome. Diagnostics (Basel), 13, Article 116. [Google Scholar] [CrossRef] [PubMed]
[27] Lee, H.G., Lim, S.B., Lee, J.L., et al. (2022) Preoperative Albu-min-Bilirubin Score as a Prognostic Indicator in Patients with Stage III Colon Cancer. Scientific Reports, 12, Article No. 14910. [Google Scholar] [CrossRef] [PubMed]
[28] Honda, T., Yamamoto, I. and Inagawa, H. (2013) Angiogenesis-, Metastasis- and Signaling Pathway-Related Factor Dynamics in Human Colon Cancer Cells following Interaction with Monocytes. Anticancer Research, 33, 2895-2900.
[29] Chittezhath, M., Dhillon, M.K., Lim, J.Y., et al. (2014) Molec-ular Profiling Reveals a Tumor-Promoting Phenotype of Monocytes and Macrophages in Human Cancer Progression. Immunity, 41, 815-829. [Google Scholar] [CrossRef] [PubMed]
[30] Sadhukhan, P. and Seiwert, T.Y. (2023) The Role of Macro-phages in the Tumor Microenvironment and Tumor Metabolism. Seminars in Immunopathology, 45, 187-201. [Google Scholar] [CrossRef] [PubMed]
[31] Qian, B.Z. and Pollard, J.W. (2010) Macrophage Diversity En-hances Tumor Progression and Metastasis. Cell, 141, 39-51. [Google Scholar] [CrossRef] [PubMed]